SHANNON HUSEBO: Open Payments
NPI 1174920524 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 104 payments from 13 companies in 2025. Trend: 2023 $1,541 · 2024 $1,325 · 2025 $1,993
Food & beverage: $1,894Education: $98
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $455 |
| Novartis Pharmaceuticals Corporation | 24 | $399 |
| ABBVIE INC. | 17 | $243 |
| Janssen Biotech, Inc. | 12 | $228 |
| GENZYME CORPORATION | 9 | $194 |
| Regeneron Healthcare Solutions, Inc. | 4 | $151 |
| PFIZER INC. | 4 | $93 |
| Amgen Inc. | 3 | $61 |
| LEO Pharma Inc. | 3 | $56 |
| Galderma Laboratories, L.P. | 2 | $36 |
Products named: Bimzelx, DUPIXENT, COSENTYX, TREMFYA, SKYRIZI, CIBINQO, OTEZLA, Rhapsido.
Industry payments across PA — which companies pay providers there.
